BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/6/2023 3:49:30 AM | Browse: 562 | Download: 1366
Publication Name World Journal of Clinical Pediatrics
Manuscript ID 85151
Country India
ISSN 2219-2808 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Retrospective Study
Article Title Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation
Manuscript Source Invited Manuscript
All Author List Puja Maitra, Subramaniam Prema, Venkatapathy Narendran and Parag K Shah
ORCID
Author(s) ORCID Number
Venkatapathy Narendran http://orcid.org/0000-0001-7436-6783
Parag K Shah http://orcid.org/0000-0002-5014-6599
Funding Agency and Grant Number
Corresponding Author Parag K Shah, Visiting Professor, Professor, Pediatric Retina and Ocular Oncology, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Avinashi Rd, Coimbatore 641014, Tamil Nadu, India. drshahpk2002@yahoo.com
Key Words Retinopathy of prematurity; Anti-vascular endothelial growth factor injection; Contraction; Crunch phenomenon
Core Tip This is a retrospective study to evaluate if anti-vascular endothelial growth factor injection could cause contraction of preexisting fibrovascular proliferation when present in severe retinopathy of prematurity.
Publish Date 2023-09-06 03:49
Citation Maitra P, Prema S, Narendran V, Shah PK. Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation. World J Clin Pediatr 2023; 12(4): 220-229
URL https://www.wjgnet.com/2219-2808/full/v12/i4/220.htm
DOI https://dx.doi.org/10.5409/wjcp.v12.i4.220
Full Article (PDF) WJCP-12-220-with-cover.pdf
Full Article (Word) WJCP-12-220.docx